Barriers to optimizing inflammatory bowel disease care in the United States

被引:7
|
作者
Spencer, Elizabeth A. [2 ]
Abbasi, Sadeea [3 ]
Kayal, Maia [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, One Gustave L Levy Pl Box 1069, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol, New York, NY USA
[3] Cedars Sinai Santa Monica Gastroenterol, Div Gastroenterol, Santa Monica, CA USA
基金
美国国家卫生研究院;
关键词
barriers; inflammatory bowel disease; insurance; HEALTH-CARE; MANAGEMENT; GUIDELINE; THERAPY;
D O I
10.1177/17562848231169652
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of market pressures into healthcare decision-making. In this review, we highlight the barriers to IBD care optimization within the context of the US insurance system and review current and proposed solutions.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Barriers to international travel in inflammatory bowel disease patients
    Aluzaite, Kristina
    Greveson, Kay
    Ben-Horin, Shomron
    Leong, Rupert
    Haj, Ola
    Schultz, Michael
    JOURNAL OF TRAVEL MEDICINE, 2021, 28 (01)
  • [42] Preventive care in inflammatory bowel disease
    Harmandar, Ferda
    Cekin, Ayhan Hilmi
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2017, 28 (04) : 307 - 310
  • [43] Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011
    Narula, Neeraj
    Borges, Lawrence
    Steinhart, A. Hillary
    Colombel, Jean-Frederic
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (06) : 868 - 874
  • [44] Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences
    Afzali, Anita
    Cross, Raymond K.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) : 2023 - 2040
  • [45] Ischemic heart disease mortality in individuals with inflammatory bowel disease: A nationwide analysis of disparities in the United States
    Pham, Hoang Nhat
    Ibrahim, Ramzi
    Sainbayar, Enkhtsogt
    Aiti, Danny
    Mouhaffel, Rama
    Shahid, Mahek
    Ozturk, Nazli Begum
    Olson, April
    Ferreira, Joao Paulo
    Lee, Kwan
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 65 : 46 - 51
  • [46] Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002
    Cohen, Russell
    Robinson, Don, Jr.
    Paramore, Clark
    Fraeman, Kathy
    Renahan, Kevin
    Bala, Mohan
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (06) : 738 - 743
  • [47] Barriers to and requirements for a successful transition in inflammatory bowel disease from pediatric to adult care in Greece
    Giouleme, Olga
    Koutsoumourakis, Anastasios
    Katsoula, Anastasia
    Katsaros, Marios
    Soufleris, Konstantinos
    Vasilaki, Konstantina
    Xinias, Ioannis
    ANNALS OF GASTROENTEROLOGY, 2023, : 541 - 548
  • [48] Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers
    Buchanan, James
    Wordsworth, Sarah
    Ahmad, Tariq
    Perrin, Angela
    Vermeire, Severine
    Sans, Miguel
    Taylor, Jenny
    Jewell, Derek
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (04) : 301 - 316
  • [49] Value-Based Health Care in Inflammatory Bowel Disease
    Ahmed, Zunirah
    Sarvepalli, Shashank
    Garber, Ari
    Regueiro, Miguel
    Rizk, Maged K.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (06) : 958 - 968
  • [50] 'Quality of Care' Standards in Inflammatory Bowel Disease: A Systematic Review
    Fiorino, Gionata
    Allocca, Mariangela
    Chaparro, Maria
    Coenen, Sofie
    Fidalgo, Catarina
    Younge, Lisa
    Gisbert, Javier P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (01) : 127 - 137